CRL:NYSE
Charles River Lbrtrs ntrntl Inc
US$166.94
arrow_upward
+1.89%(+3.10) 1D
4월 30일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoCRL의 주요 통계 생성 중...
시가
US$163.15
고가
US$167.32
저가
US$161.95
시가총액
82.20억
평균 거래량
84.69만
거래량
48.67만
52주 최고가
US$228.88
52주 최저가
US$107.60
EPS
-US$2.91
베타
1.61
유통 주식수
4934.20만
직원 수
2만
뉴스 기사
웹 소스 기반
Yahoo! Finance Canada
·
6시간 전
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Stock Titan
·
8시간 전
First commercial rat IVF service targets breeding bottlenecks
프로필
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Charles River Lbrtrs ntrntl Inc에 관한 정보